Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11350
Title: Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases
Authors: Harrell C.
Simovic Markovic, Bojana
Fellabaum C.
Arsenijevic A.
Djonov, Valentin
Arsenijevic, Nebojsa
Volarevic, Vladislav
Journal: Advances in Experimental Medicine and Biology
Issue Date: 1-Jan-2018
Abstract: © Springer International Publishing AG, part of Springer Nature 2018. Mesenchymal stem cells (MSCs) were, due to their immunomodulatory and pro-angiogenic characteristics, extensively explored as new therapeutic agents in cell-based therapy of uveitis, glaucoma, retinal and ocular surface diseases. Since it was recently revealed that exosomes play an important role in biological functions of MSCs, herewith we summarized current knowledge about the morphology, structure, phenotype and functional characteristics of MSC-derived exosomes emphasizing their therapeutic potential in the treatment of eye diseases. MSC-derived exosomes were as efficient as transplanted MSCs in limiting the extent of eye injury and inflammation. Immediately after intravitreal injection, MSC-derived exosomes, due to nano-dimension, diffused rapidly throughout the retina and significantly attenuated retinal damage and inflammation. MSC-derived exosomes successfully delivered trophic and immunomodulatory factors to the inner retina and efficiently promoted survival and neuritogenesis of injured retinal ganglion cells. MSC-derived exosomes efficiently suppressed migration of inflammatory cells, attenuated detrimental Th1 and Th17 cell-driven immune response and ameliorated experimental autoimmune uveitis. MSC-derived exosomes were able to fuse with the lysosomes within corneal cells, enabling delivering of MSC-derived active β-glucuronidase and consequent catabolism of accumulated glycosaminoglycans, indicating their therapeutic potential in the treatment of Mucopolysaccharidosis VII (Sly Syndrome). Importantly, beneficent effects were noticed only in animals that received MSC-derived exosomes and were not seen after therapy with fibroblasts-derived exosomes confirming specific therapeutic potential of MSCs and their products in the treatment of eye diseases. In conclusion, MSC-derived exosomes represent potentially new therapeutic agents in the therapy of degenerative and inflammatory ocular diseases.
URI: https://scidar.kg.ac.rs/handle/123456789/11350
Type: bookPart
DOI: 10.1007/5584_2018_219
ISSN: 00652598
SCOPUS: 85055482302
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

58

Downloads(s)

1

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.